Invo Bioscience Inc (INVO)

$0.83 -0.03 (-2.91%)
Market Cap 3.17M
Revenue (ttm) 3.02M
Net Income (ttm) -8.03M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 125,200
Avg Vol 1,316,252
Day's Range N/A - N/A
Shares Out 3.81M
Stochastic %K 26%
Beta 1.43
Analysts Hold
Price Target $2.00
PennyScam
PennyScam Sep. 13 at 4:45 PM
$INVO I’m still happy with the results of the combination. Let’s hope BMS can get this done with us. Ck
0 · Reply
PennyScam
PennyScam Sep. 13 at 2:10 AM
$INVO No one cared to mention this….. “Celgene’s Vidaza was actually being investigated in a Ceplene/IL-2 combination.”https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019709-41/FR?utm_source=chatgpt.com Interesting how studies are ongoing . This is substantial folk. They were going the distance with plans to go phase 2 to follow phase 1 investigative study. Interesting stuff. Ck
2 · Reply
PennyScam
PennyScam Sep. 13 at 1:42 AM
$INVO So there is potential. Just sayin. Ck
0 · Reply
PennyScam
PennyScam Sep. 13 at 1:40 AM
$INVO For the curious minded folk. https://www.ema.europa.eu/en/medicines/human/EPAR/ceplene
0 · Reply
PennyScam
PennyScam Sep. 13 at 1:37 AM
$INVO To random people with interest. I was just reminded of something from the past which ties this BMS deal closer to us. Well little do many know that Celgene acquired an asset before it was acquired by BMS. This asset transaction allowed Celgene to gain full ownership of DEL106, an engineered IL-2 mutein Fc fusion protein. Now why does this make a big deal to Cytovia folk? Well don’t you legacy guys remember the combination drug that made Ceplene a hit in that Remain study. Remember when they brought it up in past like it was a serious loss and that we were going to try other combinations. What a joke this is people. A little irritating but also brilliant. I respect smart plans. This is a good situation to be in. I like. I see lots of potential here. I love Celgene. Celgene runs a very unique ship. It’s a giver. Best to you Legacy folk. Be nicer to yourselves. Ck
0 · Reply
PennyScam
PennyScam Sep. 11 at 4:17 PM
$INVO To top it off guys, this is where that insert from Bruce plays a role. That potential reform for registrations. To have the ability to increase the shelf. The speed in the mechanics would be very beneficial. Hmmm. This would really benefit Astra if they chose to acquire BMS while all was happening with BMS and potentially us. Oh man. Hilarious. I like this plan even if it doesn’t happen. Crazy how we had BMS / Astra rumblings. Maybe they were planning something. Maybe. Just maybe they wer getting the playing field ready for us. Lots of players in the game if any of this is true. Stay tuned people. Ck
0 · Reply
PennyScam
PennyScam Sep. 11 at 2:54 PM
$INVO Are you guys feeling the electricity in the air? Just knowing where we stand in the chaos is good enough for me. Stay strong. Stay alive. Ck
0 · Reply
PennyScam
PennyScam Sep. 11 at 2:37 PM
$INVO Im thinking nothing is finalizing this year. No real liquidity but answers will be given. The US Trustee should clear our final return situation in October which doesn’t do much other than expose the rights. I’m thinking Yaday Health is ready to invest its money into BMS transaction if it happens. This way Teper gets his top up, we have our claim recognized, 100 million is used to finance runway for the next two years while in lock up with potentially BMS. I think once this potential deal is done then maybe Astra should come into the picture shortly after. So we may be locked up for 2 more years in merger and then Astra comes into the picture. Patent cliff is near for BMS. Plenty of time to lock in a deal. What throws me off is my interest in Ipsen. 😂😂😂 Marc de Garidel isnt sniffing around with Alex for shits and giggles. I would like that acquisition to happen as well. Maybe there are multiple deals. It would be nice that some of my Ipsen homework wasn’t a waste of time. 😂😂😂
0 · Reply
PennyScam
PennyScam Sep. 11 at 2:18 PM
$INVO Maybe Yaday Health Fund would come in on a financing level with the BMS merger into Cytovia / Naya. Oh I can see this big time. Then you have all cleaned up for one simple transaction with Alexion or Astra Zeneca pending what they want to do. I wonder if Dizal will fall into this. Wow. That would be a nice enhancement to this new oncology build out. Ck
0 · Reply
PennyScam
PennyScam Sep. 10 at 9:50 PM
$INVO This is interesting. I’m starting to wonder if BMS comes in first to scoop up one thing before Astra comes in soon after to merge with BMS after it takes Cytovia. That would be easier for AZN. Hmmmm. Ck
1 · Reply
Latest News on INVO
No data available.
PennyScam
PennyScam Sep. 13 at 4:45 PM
$INVO I’m still happy with the results of the combination. Let’s hope BMS can get this done with us. Ck
0 · Reply
PennyScam
PennyScam Sep. 13 at 2:10 AM
$INVO No one cared to mention this….. “Celgene’s Vidaza was actually being investigated in a Ceplene/IL-2 combination.”https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019709-41/FR?utm_source=chatgpt.com Interesting how studies are ongoing . This is substantial folk. They were going the distance with plans to go phase 2 to follow phase 1 investigative study. Interesting stuff. Ck
2 · Reply
PennyScam
PennyScam Sep. 13 at 1:42 AM
$INVO So there is potential. Just sayin. Ck
0 · Reply
PennyScam
PennyScam Sep. 13 at 1:40 AM
$INVO For the curious minded folk. https://www.ema.europa.eu/en/medicines/human/EPAR/ceplene
0 · Reply
PennyScam
PennyScam Sep. 13 at 1:37 AM
$INVO To random people with interest. I was just reminded of something from the past which ties this BMS deal closer to us. Well little do many know that Celgene acquired an asset before it was acquired by BMS. This asset transaction allowed Celgene to gain full ownership of DEL106, an engineered IL-2 mutein Fc fusion protein. Now why does this make a big deal to Cytovia folk? Well don’t you legacy guys remember the combination drug that made Ceplene a hit in that Remain study. Remember when they brought it up in past like it was a serious loss and that we were going to try other combinations. What a joke this is people. A little irritating but also brilliant. I respect smart plans. This is a good situation to be in. I like. I see lots of potential here. I love Celgene. Celgene runs a very unique ship. It’s a giver. Best to you Legacy folk. Be nicer to yourselves. Ck
0 · Reply
PennyScam
PennyScam Sep. 11 at 4:17 PM
$INVO To top it off guys, this is where that insert from Bruce plays a role. That potential reform for registrations. To have the ability to increase the shelf. The speed in the mechanics would be very beneficial. Hmmm. This would really benefit Astra if they chose to acquire BMS while all was happening with BMS and potentially us. Oh man. Hilarious. I like this plan even if it doesn’t happen. Crazy how we had BMS / Astra rumblings. Maybe they were planning something. Maybe. Just maybe they wer getting the playing field ready for us. Lots of players in the game if any of this is true. Stay tuned people. Ck
0 · Reply
PennyScam
PennyScam Sep. 11 at 2:54 PM
$INVO Are you guys feeling the electricity in the air? Just knowing where we stand in the chaos is good enough for me. Stay strong. Stay alive. Ck
0 · Reply
PennyScam
PennyScam Sep. 11 at 2:37 PM
$INVO Im thinking nothing is finalizing this year. No real liquidity but answers will be given. The US Trustee should clear our final return situation in October which doesn’t do much other than expose the rights. I’m thinking Yaday Health is ready to invest its money into BMS transaction if it happens. This way Teper gets his top up, we have our claim recognized, 100 million is used to finance runway for the next two years while in lock up with potentially BMS. I think once this potential deal is done then maybe Astra should come into the picture shortly after. So we may be locked up for 2 more years in merger and then Astra comes into the picture. Patent cliff is near for BMS. Plenty of time to lock in a deal. What throws me off is my interest in Ipsen. 😂😂😂 Marc de Garidel isnt sniffing around with Alex for shits and giggles. I would like that acquisition to happen as well. Maybe there are multiple deals. It would be nice that some of my Ipsen homework wasn’t a waste of time. 😂😂😂
0 · Reply
PennyScam
PennyScam Sep. 11 at 2:18 PM
$INVO Maybe Yaday Health Fund would come in on a financing level with the BMS merger into Cytovia / Naya. Oh I can see this big time. Then you have all cleaned up for one simple transaction with Alexion or Astra Zeneca pending what they want to do. I wonder if Dizal will fall into this. Wow. That would be a nice enhancement to this new oncology build out. Ck
0 · Reply
PennyScam
PennyScam Sep. 10 at 9:50 PM
$INVO This is interesting. I’m starting to wonder if BMS comes in first to scoop up one thing before Astra comes in soon after to merge with BMS after it takes Cytovia. That would be easier for AZN. Hmmmm. Ck
1 · Reply
bruceleeboy
bruceleeboy Sep. 10 at 2:32 AM
$IVF $INVO Tep is with his peoples. He’s cultivating his audience… He’s excited…
1 · Reply
PennyScam
PennyScam Sep. 10 at 1:21 AM
$INVO I didn’t know this about Massimo. Interesting….. Ck
0 · Reply
PennyScam
PennyScam Sep. 10 at 1:05 AM
$INVO Any thoughts on Delbert Laboratories and the strong connections with Bristol Meyers? Interesting. It’s good that they mentioned only the two drugs on this random Norwegian pharma site. Ck
0 · Reply
PennyScam
PennyScam Sep. 7 at 5:13 PM
$INVO Ok. We’ve got geopolitical tensions in Iran, changing U.S. trade policies, and volatility in U.S. midterm elections. All pretty good reasons for a tiny little market slight downturn. Some concerns about rising debt and potential for interest rate hikes could sway market to fall. Is it baked in? Most likely. So what the heck are we waiting for people. Days are numbered. Focus Teper! 😂😂😂😂 Is the window closing people and can we still do this next year??? I see the doors are wide open for some people. Just not open to others. Is there a club password?! Do I need to bend over? What’s the protocol? I wish someone would unlock our benefits. Son of a b……😂😂😂😂😂😂Ck
0 · Reply
PennyScam
PennyScam Sep. 7 at 3:34 PM
$INVO Hey folk, any thoughts on why Naya hasn’t addressed the separation of Naya into seperate companies. Four months with no news. It doesn’t take that long to do this type of transaction. I’m super confused. 🤔 Ck
1 · Reply
PennyScam
PennyScam Sep. 7 at 2:28 PM
$INVO No liquidity for us Longs until 2027/ 2028. Yaday Health will possibly come in the Fall and do it’s financing then next year we see some sort of deal happen in late Spring or early Fall 2027. Hopefully AZN comes in at the same time. I believe Cellectis may come into the framework as well in 2027. Somehow that’s another leg that could be taken. Our partnership with Cellectis is there and Astra has its 44 percent stake. Ck
1 · Reply
PennyScam
PennyScam Sep. 5 at 12:44 PM
$INVO Guys, Pretty sure Yaday Health is just an investment vehicle for the family behind the fund. Could be used as catalyst but Teper isn’t in it to help us. I see that family funded it and is making a big investment here which is nice to see. I’m thinking Teper is just making his earning circle stronger. He’ll make fees off the fund while later rewarded with equity after deal completes. Maybe he is given something by fund as well as his direct ownership. Topping up. It’s free to do. Might as well get when the getting is good. I think we still have a way to go. I see us going through next year without. These guys really want to stretch things out as much as they can as it plays in their favour. Next week everything starts over. RESET. 😂😂😂 I wish we could start everything again. Only in my dreams. 😂😂😂Ck
1 · Reply
PennyScam
PennyScam Sep. 3 at 6:23 PM
$INVO RK. Biomunex fits surprisingly close to the Cytovia/NAYA side of your network. I think Marc and Ipsen see us as a good combination. Maybe we line up a partnership with Biomunex. Keep everything separate. Who knows. Trust you are doing well. Ck https://www.biomunex.com/about-biomunex/
1 · Reply
PennyScam
PennyScam Sep. 3 at 5:22 PM
$INVO BDC and Closed Ends win here. Lots of perk scraps for the wolves of wallstreet. It does suck a little to know us little folk have to wait. I’m also sort of glad I know more now. Thanks Bruce for the little scrap there. I would give you a grenade with a pulled pin but unfortunately I have no more grenades left. Knowing this info alone gives me enough gas to survive till next year. Systemic change takes time. I hate it. I do like things much better now knowing theres no choice in this and its all out of my hands. We are all just waiting for SEC to make adjustment. Yaday will also benefit greatly with the change. 😂 eh RK. Wow. Ck
0 · Reply
PennyScam
PennyScam Sep. 3 at 5:13 PM
$INVO The proposed amendments would make Form S-3 available to significantly more issuers, extend certain registration and communication benefits to a broader set of issuers, and expand the ability to incorporate information by reference into Form S-1. The proposed amendments also would make conforming changes for certain business development companies and registered closed-end investment companies that use Form N-2, permit broad-based advertising for certain insurance products, and preempt State securities law registration and qualification requirements for all registered offerings.
0 · Reply
PennyScam
PennyScam Sep. 3 at 4:52 PM
$INVO I don’t know why none of you Fuckers mentioned anything about the registration reform. I get you all are bunch of dumb pricks but c’mon now. Future registration reform will surely affect this deal. Don’t you guys know whose involved here. These people are kings of paying nothing. We will now wait until next year and get that final rule behind us. Fuck I hate the system. Once we get this effectiveness then we can start to move forward next year. Astra will then do what they need to do and change the whole deal in one giant step. I’ll just wait till then for mine. Hopefully they can build that fucking share price back to 250 plus especially now that I’m waiting for another 18 months. Mother Fuckers!!! The reform is quite extensive. That’s going to help consolidate everything on a massive scale. So much for the fun coming. It’s all good. Knowing is half the battle. Stay strong. Stay you. Ck
0 · Reply
PennyScam
PennyScam Sep. 3 at 3:58 PM
$INVO Yaday Health’s potential investment should help finance studies for a year. Tepers 100 million investment could be a great addition to fuel journey to 2028. 🤞👍🏻Cheers. Ck
0 · Reply